June 18, 2009 - Hologic Inc. has received Food and Drug Administration (FDA) clearance for its R2 DigitalNow HD software, an application designed to process digitized screen-film mammograms for comparison purposes. The product is now available worldwide.
By collaborating with radiologists to understand the demands of reading digital mammograms, Hologic created the R2 DigitalNow HD software, which adapts each digitized film image to a selected contrast and tissue intensity that models a digital mammography system. It also embeds a series of look-up tables in the image that allow Integrated Healthcare Enterprise (IHE) mammography conformant workstations to draw out less evident regions of density within digitized films.
The DigitalNow HD software is designed to enhance workflow by promoting consistency in the digital mammography reading environment. One of its capabilities is that it images already digitized by R2 DigitalNow software and stored in PACS can be routed to R2 DigitalNow HD and reprocessed, according to the company.
For more information: www.hologic.com
October 30, 2025 
